Ambry Genetics will hold their annual #GeneticCounseling#BoardsReview again this year. There are three opportunities to help you study with a trivia-style event. All three events on June 28, July 11, or July 20 will feature the same content.
https://t.co/KQnl3H4JmX
#genechat
Margo Gallegos, MS, CGC, Genomic Science Liaison, was a genetic counseling student in 2013. She reflects on the rapid growth of genetic testing. Her experience shows how this decision created a whole new world of information. #KeepGenesFree
https://t.co/5MEOCNmtlB
With deep sadness, we share news that our colleague and friend Cecelia Bellcross has passed away. Cecelia was extraordinary founder of @EmoryGCTP and leader in genetic counseling field. We remember her dedication to her students cc @LaurenLichten https://t.co/olyzcUSRj0
Ten years ago, the Supreme Court made a momentous decision about your genetic information. Justices ruled naturally occurring gene sequences cannot be patented by corporations. This week we will look back at the decision and hear from people who played a role. #KeepGenesFree
Well, hon, there’s one vendor who won’t be at the 2023 HonFest — Planned Parenthood of Maryland.
HonFest organizers said PPM now represents a "hot topic"issue, making them too controversial for a vendor booth. @BaltimoreBanner
https://t.co/POGpunnq2n
Last month, I proudly signed into law the Trans Health Equity Act.
By signing this act into law, we took a clear stand as a people and state: Transgender people are welcome here, they are part of the fabric of Maryland, and we will not bend to hateful attacks from extremists.
Dear straight allies (and straight people in general)... please see this below and help. We're sending out an distress signal, and as Pride season is here, we need your help. #Pride2023
I've also had the pleasure of working with amazing people like @margofgallegos @DianeKoellerCGC @KimZayhowski @AndyLCantor as part of the Gender Inclusive Subcommittee of @GeneticCouns We are all doing this important work TOGETHER for our colleagues and patients #genechat 🧵(5/5)
"Variant reclassification in a large cardiogenetic testing cohort" will be presented as an oral platform March 16, 11 am-12:30 pm MT. Learn about Ambry’s experience tailoring variant classification based on disease type and view poster #P575 at #ACMGMtg23. https://t.co/C1FJqpbe6Z
Our GSL and MSL team has written an #AmericanHeartMonth Spotlight on sudden cardiac arrest (SCA) to answer the questions everyone is asking: What causes #SCA? Should #athletes be screened for heart disease? What role does #genetictesting play? Find out: https://t.co/z4eycFRHie
REALM and Ambry lit our building for #RareDiseaseDay. Come back March 2 to meet our Gene Team and learn about the gene of the month. You know your patients. #AmbryKnowsGenes.
Partner with us to end diagnostic odysseys sooner and improve care for patients with rare diseases.
At Ambry, exome patients are a Patient for Life as we continuously reanalyze patient data and proactively issue reclassification reports as new genes are discovered. This initiative has reclassified 5% of previously negative reported exome results. https://t.co/2kAgBkWnrk